Search results
5 questions for the Internet Society’s Andrew Sullivan
Politico· 17 hours agoBut as a change in the executive branch would almost surely lead to the ouster of DOJ antitrust...
Microsoft’s $650 million deal with Inflection AI is facing FTC probe: report
Market Watch· 2 days agoCompanies are required to report and gain FTC approval for all transactions worth more than $119.5...
DOJ, FTC set to open antitrust probe into Microsoft, Nvidia and OpenAI: Reports
The Hill via Yahoo News· 2 days agoThe Department of Justice (DOJ) and federal regulators will open an antitrust investigation into...
Why the few big AI players worry US antitrust regulators
Reuters via Yahoo Finance· 21 hours agoU.S. antitrust enforcers are digging into Big Tech's role in the artificial intelligence (AI) boom,...
Democrats ramp up patent fight with drug industry in bid to lower prices
Washington Post· 20 hours agoDemocrats have hit on a new tactic in their long battle with drug companies: challenge patents that...
Why Trump is finding new friends in Silicon Valley
Politico· 23 hours agoThe $300,000-per-person fundraiser, hosted at billionaire venture capitalist David Sacks’ Pacific Heights mansion, included many of the Silicon Valley...
How a Depression-era law could be used to make booze cheaper
Orange County Register· 17 hours agoIt would also be the latest aggressive step by FTC Chair Lina Khan, who recently led the agency to...
How a Depression-era law could be used to make your booze cheaper
CNN Business via Yahoo Finance· 20 hours agoFederal regulators are planning to use a rarely enforced law from the Great Depression to allege...
FTC Opens Antitrust Probe of Microsoft AI Deal
The Wall Street Journal· 2 days agoThe FTC has been sifting through AI investments made by leading companies such as Microsoft and Google-owner Alphabet FTC Chair Lina Khan has expressed...
Democrats ramp up patent fight with drug industry in bid to lower prices
Anchorage Daily News· 17 hours agoDemocrats have hit on a new tactic in their long battle with drug companies: challenge patents that...